WallStreetZenWallStreetZen

NASDAQ: GTHX
G1 Therapeutics Inc Earnings & Revenue

GTHX past revenue growth

How has GTHX's revenue growth performed historically?
Company
46.55%
Industry
82.81%
Market
19.67%
GTHX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
GTHX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
GTHX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

GTHX earnings and revenue history

Current Revenue
$84.0M
Current Earnings
-$30.6M
Current Profit Margin
-36.4%

GTHX Return on Equity

Current Company
-74.8%
Current Industry
16.8%
Current Market
28.2%
GTHX's Return on Equity (-74.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when GTHX announces earnings.

GTHX Return on Assets

Current Company
-24.3%
Current Industry
3.2%
GTHX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GTHX Return on Capital Employed

Current Company
-26.72%
Current Industry
-42.4%
GTHX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GTHX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GTHX$84.04M-$18.05M-$30.59M+74.43%N/A
NVCT$0.00-$22.38M-$22.38MN/AN/A
TVGN$0.00-$49.37M-$51.21MN/AN/A
SGMT$2.00M-$27.78M-$27.92MN/AN/A
OMGA$4.94M-$84.32M-$92.28M+246.23%N/A

GTHX earnings dates

Next earnings date
Jul 31, 2024

G1 Therapeutics Earnings & Revenue FAQ

What were GTHX's earnings last quarter?

On Invalid Date, G1 Therapeutics (NASDAQ: GTHX) reported Q1 2024 earnings per share (EPS) of -$0.20, up 62.26% year over year. Total G1 Therapeutics earnings for the quarter were -$10.22 million. In the same quarter last year, G1 Therapeutics's earnings per share (EPS) was -$0.53.

If you're new to stock investing, here's how to buy G1 Therapeutics stock.

What was GTHX's earnings growth in the past year?

As of Q2 2024, G1 Therapeutics's earnings has grown year over year. G1 Therapeutics's earnings in the past year totalled -$30.59 million.

What is GTHX's earnings date?

G1 Therapeutics's earnings date is Invalid Date. Add GTHX to your watchlist to be reminded of GTHX's next earnings announcement.

What was GTHX's revenue last quarter?

On Invalid Date, G1 Therapeutics (NASDAQ: GTHX) reported Q1 2024 revenue of $14.48 million up 11.82% year over year. In the same quarter last year, G1 Therapeutics's revenue was $12.95 million.

What was GTHX's revenue growth in the past year?

As of Q2 2024, G1 Therapeutics's revenue has grown 46.55% year over year. This is 36.25 percentage points lower than the US Biotechnology industry revenue growth rate of 82.81%. G1 Therapeutics's revenue in the past year totalled $84.04 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.